Key Highlights
- Twist Bioscience and Element Biosciences partner to develop the Twist for Element Exome Workflow for AVITI™ System, promoting efficient next-generation sequencing.
- The collaboration aims to provide researchers with an economical, streamlined approach to sequencing, leveraging Twist’s Exome 2.0 panel for high-quality, low-cost data.
- Exome 2.0 is designed to detect rare and inherited diseases and germline cancers, boasting high uniformity and a low off-target rate.
Source: Business Wire
Notable Quotes
- “Pairing Twist’s robust NGS workflows with Element’s AVITI technology will offer customers an economical and streamlined approach to next generation sequencing,” – Emily M. Leproust, Ph.D., CEO and co-founder at Twist Bioscience
- “With the Twist for Element Exome Workflow, we are able to provide our customers with easy access to Twist’s Exome 2.0 panel and high performing library preparation and target enrichment reagents,” – Molly He, Ph.D., CEO and co-founder at Element Biosciences
SoHC's Take
This collaboration between Twist Bioscience and Element Biosciences marks a significant step forward in the genomics and synthetic biology fields. By combining Twist Bioscience’s advanced synthetic DNA technology with Element Biosciences’ innovative AVITI system, the partnership is poised to enhance the accessibility and efficiency of next-generation sequencing (NGS). The introduction of the Twist for Element Exome Workflow represents a promising development for researchers, offering a streamlined and cost-effective solution for high-quality genomic data acquisition.
The potential of this collaboration to accelerate scientific discoveries and advancements in the diagnosis and treatment of diseases is immense. By reducing the complexity and cost associated with sequencing, the partnership is not just a boon for the research community but also signifies progress towards more personalized and precise medical interventions. This initiative is a testament to the power of collaboration in driving technological innovation and expanding the horizons of scientific research and healthcare.
